Showing results (351-360 of 735) with videos related to

Sort By:
Pageof 74
Cancer Research|November 21, 2024
Multiomics Analysis Reveals Molecular Changes during Early Progression of Precancerous Lesions to Lung Adenocarcinoma in Never-SmokersYun-Ching Chen, Chia-Lang Hsu, Hui-Min Wang, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 2011
Single-walled carbon nanotubes induce airway hyperreactivity and parenchymal injury in miceWan-Yu Hsieh, Cheng-Chung Chou, Chao-Chi Ho, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 30, 2014
Robot-assisted renal transplantation in the retroperitoneumMeng-Kun Tsai, Chih-Yuan Lee, Ching-Yao Yang, et al.
World Journal of Surgery|February 10, 2009
Gastrointestinal stromal tumor of the small intestine: a clinicopathologic study of 70 cases in the postimatinib eraChun-Chieh Huang, Ching-Yao Yang, I-Rue Lai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2015
Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomasJen-Chieh Lee, Yung-Ming Jeng, Jau-Yu Liau, et al.
The American Journal of Surgical Pathology|September 18, 2014
Leiomyosarcoma with alternative lengthening of telomeres is associated with aggressive histologic features, loss of ATRX expression, and poor clinical outcomeJau-Yu Liau, Jia-Huei Tsai, Yung-Ming Jeng, et al.
Annals of Surgical Oncology|November 21, 2018
The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell CarcinomaMong-Wei Lin, Yen-Lin Huang, Ching-Yao Yang, et al.
Toxicology and Applied Pharmacology|December 17, 2009
Inorganic mercury causes pancreatic beta-cell death via the oxidative stress-induced apoptotic and necrotic pathwaysYa Wen Chen, Chun Fa Huang, Ching Yao Yang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma--a randomized phase II trialChiun Hsu, Sung-Hsin Kuo, Fu-Chang Hu, et al.
EMBO Molecular Medicine|March 28, 2023
PM2.5 promotes lung cancer progression through activation of the AhR-TMPRSS2-IL18 pathwayTong-Hong Wang, Kuo-Yen Huang, Chin-Chuan Chen, et al.
Pageof 74